Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease

Yumin Wang(Central South University), Jichen Du(Peking University)
Frontiers in Pharmacology
November 23, 2021
10.3389/fphar.2021.757161
Cited by 95

Related Papers

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
|Drug Resistance Updates|2023|236
Passive repetitive stretching is associated with greater muscle mass and cross-sectional area in the sarcopenic muscle
|Scientific Reports|2021|9
Interstitial lung disease presents with varying characteristics in patients with non-Hodgkin lymphoma undergoing rituximab-containing therapies
|Annals of Hematology|2024|3